Edition:
United States

Nice Ltd (NICE.O)

NICE.O on Nasdaq

80.08USD
25 Sep 2017
Change (% chg)

$-1.76 (-2.15%)
Prev Close
$81.84
Open
$80.92
Day's High
$80.92
Day's Low
$79.44
Volume
120,404
Avg. Vol
146,377
52-wk High
$83.53
52-wk Low
$63.72

Chart for

About

NICE Ltd., formerly NICE-Systems Ltd., is a global enterprise software provider. The Company's segments include Customer Interactions Solutions, and Financial Crime and Compliance Solutions. The Customer Interactions Solutions segment provides data driven insights that enable businesses to deliver personalized experience to... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $4,899.45
Shares Outstanding(Mil.): 60.35
Dividend: 0.16
Yield (%): 0.78

Financials

  Industry Sector
P/E (TTM): -- 36.63 16.08
EPS (TTM): -- -- --
ROI: -- 11.22 14.60
ROE: -- 11.99 14.03

UK finds Roche bladder cancer drug too costly for routine use

LONDON Britain's healthcare cost-effectiveness agency NICE has decided Roche's new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances.

Aug 02 2017

UK finds Roche bladder cancer drug too costly for routine use

LONDON, Aug 2 Britain's healthcare cost-effectiveness agency NICE has decided Roche's new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances.

Aug 02 2017

BRIEF-Nice reports 35 pct growth in Q1 revenue

* Nice reports 35 pct growth in revenue for the first quarter 2017

May 04 2017

BRIEF-Nice Ltd says selected for San Francisco Dept Of Emergency Management's 9-1-1 center upgrade

* Nice Ltd - San Francisco Department Of Emergency Management selects Nice for 9-1-1 center upgrade Source text for Eikon: Further company coverage:

Apr 18 2017

Earnings vs. Estimates